David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Ecopetrol
EC
$34.5B
| $928K | ﹤0.01% |
107,768
-86,883
| -45% | -$613K |
|
|
ACRE
2377
Ares Commercial Real Estate
ACRE
$262M
| $926K | ﹤0.01% |
84,553
-17,394
| -17% | -$181K |
|
|
DISH
2378
CALL
DELISTED
DISH Network Corp.
DISH
| $925K | ﹤0.01% |
20,000
-47,600
| -70% | -$2.29M |
|
2379
Vishay Intertechnology
VSH
$4.8B
| $921K | ﹤0.01% |
75,440
+19,528
| +35% | +$224K |
|
2380
Culp Inc
CULP
$44.3M
| $917K | ﹤0.01% |
34,988
+411
| +1% | +$10.2K |
|
2381
Scansource
SCSC
$1.14B
| $915K | ﹤0.01% |
22,659
-1,476
| -6% | -$51.5K |
|
|
SKX
2382
PUT
DELISTED
Skechers
SKX
| $914K | ﹤0.01% |
30,000
-343,200
| -92% | -$10.3M |
|
|
TNAV
2383
DELISTED
Telenav Inc.
TNAV
| $914K | ﹤0.01% |
154,957
+8,703
| +6% | +$50.2K |
|
2384
Golub Capital BDC
GBDC
$3.4B
| $913K | ﹤0.01% |
53,866
+39,816
| +283% | +$638K |
|
|
LUMO
2385
PUT
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $910K | ﹤0.01% |
5,556
+3,334
| +150% | +$676K |
|
|
AKS
2386
CALL
DELISTED
AK Steel Holding Corp
AKS
| $909K | ﹤0.01% |
+220,000
| New | +$631K |
|
2387
First Busey Corp
BUSE
$2.48B
| $908K | ﹤0.01% |
44,329
+2,878
| +7% | +$56.1K |
|
|
ECYT
2388
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $907K | ﹤0.01% |
292,734
+48,511
| +20% | +$158K |
|
|
PGEM
2389
DELISTED
Ply Gem Holdings, Inc.
PGEM
| $904K | ﹤0.01% |
64,327
+28,950
| +82% | +$310K |
|
2390
Usana Health Sciences
USNA
$255M
| $902K | ﹤0.01% |
14,852
-45,512
| -75% | -$2.68M |
|
2391
DXP Enterprises
DXPE
$2.92B
| $900K | ﹤0.01% |
51,267
+34,005
| +197% | +$557K |
|
2392
Scotiabank
BNS
$113B
| $899K | ﹤0.01% |
18,805
+5,212
| +38% | +$213K |
|
|
KLXI
2393
DELISTED
KLX Inc.
KLXI
| $898K | ﹤0.01% |
33,121
-158,943
| -83% | -$3.89M |
|
2394
CALL
Automatic Data Processing
ADP
$112B
| $897K | ﹤0.01% |
+10,000
| New | +$838K |
|
2395
Orion Group Holdings
ORN
$378M
| $896K | ﹤0.01% |
172,999
-18,483
| -10% | -$72.7K |
|
2396
HSBC
HSBC
$358B
| $894K | ﹤0.01% |
32,248
+9,091
| +39% | +$269K |
|
2397
Meritage Homes
MTH
$4.79B
| $892K | ﹤0.01% |
+48,912
| New | +$779K |
|
|
QLTI
2398
DELISTED
QLT Inc
QLTI
| $892K | ﹤0.01% |
448,292
+22,224
| +5% | +$53K |
|
2399
Korn Ferry
KFY
$4.33B
| $887K | ﹤0.01% |
31,347
-3,084
| -9% | -$88.4K |
|
2400
FTI Consulting
FCN
$4.19B
| $885K | ﹤0.01% |
24,935
-21,921
| -47% | -$735K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.